Follow The Filings

NVNO enVVeno Medical

enVVeno Medical earnings company data as of 8:00 PM ET 10/28

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 30 Oct EPS -3.27 — —
Rev — — —

Insider trades

Open-market buys and sales by NVNO's executives, directors and 10% owners in the last 12 months, from their Form 4s

All NVNO insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $4,922 sold by 1 insider under 10b5-1 plans
  1. Francis Duhay Director
    Planned sale
    $123 11 shares at $11.21 0.5% of stake
    Traded Sep 11 Filed Sep 14
    ↗
  2. Francis Duhay Director
    Planned sale
    $1,443 140 shares at $10.31 5.6% of stake
    Traded Jun 11 Filed Jun 12
    ↗
  3. Francis Duhay Director
    Planned sale
    $1,613 140 shares at $11.52 5.3% of stake
    Traded Mar 12 Filed Mar 13
    ↗
  4. Francis Duhay Director
    Planned sale
    $1,742 4,900 shares at $0.3600 5% of stake
    Traded Dec 11, 2025 Filed Dec 12, 2025
    ↗

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
SCHEDULE 13D/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,7.01,8.01,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13D — Filing Doc
SCHEDULE 13D — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
8-K 5.03,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc
8-K 5.03,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 7.01,9.01 Filing Doc
DEF 14A Filing Doc
10-Q Filing Doc
DEFA14A Filing Doc
424B5 Filing Doc

Source: SEC EDGAR submissions, updated 11 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.